Mode
Text Size
Log in / Sign up
N/A Completed N=80 Randomized Single-blind Supportive Care

Validation of the BREATHE Asthma Intervention Trial

Source: ClinicalTrials.gov NCT03300752 ↗
Enrolled (actual)
80
Serious AEs
1.3%
Results posted
Sep 2021
Primary outcomePrimary: Asthma Control Questionnaire (ACQ) Score — 2.94; 2.63; 2.17; 2.16 score on a scale

Summary

The overall goal of this study to preliminarily validate a novel intervention delivered by primary care providers (PCPs) to their Black adult patients with uncontrolled asthma in federally qualified health centers (FQHCs).

Outcome Measures

OutcomeResultp-value
PRIMARY
Asthma Control Questionnaire (ACQ) Score
2.94; 2.63; 2.17; 2.16; 2.22; 2.35
SECONDARY
Asthma Quality of Life Questionnaire (AQLQ) Score
3.50; 3.65; 4.03; 4.07; 3.97; 4.18
SECONDARY
Medication Adherence Record Scale-Asthma (MARS-A) Score
3.95; 3.88; 4.07; 4.12; 4.28; 4.18

Eligibility Criteria

PROVIDER RECRUITMENT

Inclusion Criteria

  • PCPs (MDs and Nurse Practitioners (NPs)/Physician Assistants (PAs)) working in family, primary or internal medicine care services
  • Who have at least 40 adult patients with persistent asthma (defined as having been prescribed ICS) on their patient panel

Exclusion Criteria

  • PCPs whose primary focus is outside of adult health services (family, primary or internal medicine), such as behavioral health, pediatrics and Obstetrics and Gynaecology (OB-GYN)

PATIENT RECRUITMENT

Inclusion Criteria

Patients must be

  • adults (> or = 18 years of age) who self-report race as Black or African American
  • with PCP-diagnosed persistent asthma
  • prescribed ICS
  • receiving asthma care at participating FQHCs
  • who have uncontrolled asthma
  • have erroneous personal health and/or negative ICS beliefs

Exclusion Criteria

  • participation in Phase 1 (Part 1) of the BREATHE trial (focus groups)
  • non-English speaking
  • serious mental health conditions (e.g., psychosis) that preclude completion of study procedures or confound analyses
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03300752). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search